Sarcoma

At a Glance

Sarcoma refers to malignant tumors that originate in soft tissues such as muscle, fat, blood vessels, and tendons, and is a disease category encompassing various subtypes of bone and soft tissue.

A palpable mass or swelling typically appears, and if the tumor compresses nerves or organs, pain or difficulty breathing may occur.

How the disease works

The exact cause is unknown, but exposure to certain chemicals, a history of radiation therapy, and specific genetic disorders may be associated with an increased risk.

Sarcoma is a cancer in which the system regulating cell growth and division breaks down, causing abnormal cells to proliferate and invade surrounding tissues or spread to other areas.

Variations in presentation among individuals

Individual risk may vary depending on exposure history and genetic background, but in many patients, no distinct single risk factor is identified.

The broad framework of diagnosis and management

The course varies depending on the tissue of origin, location, size, compression of surrounding structures, and whether metastasis has occurred; some may cause pain or functional decline as they progress.

Diagnosis is made by synthesizing imaging tests and histopathological examination based on medical history and physical examination, with biopsy generally being important for definitive diagnosis.

Current status of treatment

Because sarcomas have diverse subtypes, it is difficult to confirm the diagnosis based on imaging findings alone; pathological interpretation of biopsy specimens and, if necessary, molecular testing must be interpreted in conjunction with clinical information.

Management is planned considering the tumor subtype, extent, location, and the patient's overall condition, and surgery, radiation therapy, and chemotherapy may be used alone or in combination.

The current mainstay of treatment is surgical removal of the tumor, with radiation therapy or chemotherapy added or combined as appropriate.

How to read clinical trials

Clinical trial registration only indicates that a study exists and does not prove efficacy or approval. The NCT00615329 referenced in this material is a record of a terminated observational study for which results have not been reported.

Points to verify during clinical consultations

In clinical practice, it is important to verify the timing of mass occurrence and its changes, changes in pain and function, history of radiation therapy and chemical exposure, family history, results of imaging and biopsy performed, and treatment goals.